Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Bio-Techne (TECH)

Bio-Techne declares $0.08 quarterly dividend, payable Nov. 23, if Merck deal not closed

Neutral Impact 3 of 5 shareholder

Bio-Techne's board declared a $0.08 per share cash dividend for the quarter ended September 30, 2026. The payment is conditional on the pending transaction with Merck KGaA, Darmstadt, Germany not closing on or before the November 13, 2026 record date, so the dividend tie-in to that deal matters to shareholders.

Key points

  • Dividend of $0.08 per share for the quarter ended September 30, 2026
  • Payable November 23, 2026 to common shareholders of record at close of business November 13, 2026
  • Dividend applies only if the Merck KGaA transaction has not closed on or before November 13, 2026
  • Future dividends will be considered by the Board on a quarterly basis

The filing

CompanyBio-Techne (TECH)
Form8-K, current report
Filed with the SECNov 3, 2026, 8:30 PM ET
Accession number0001104659-26-122283

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 7, 2026, 11:17 PM ET, from the text of the filing and its press-release exhibits only.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.